{'fraction_non_alphanumeric': 0.05191873589164785, 'fraction_numerical': 0.012791572610985704, 'mean_word_length': 4.859030837004405, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Differential expression of Qa-m2 alloantigen on murine hemopoietic progenitor cells. Selective enrichment for megakaryocyte progenitors.

The selective expression of Qa-m2 antigen on murine megakaryocyte colony-forming cells (MEG-CFC) has been demonstrated. A monoclonal antibody defining the Qa-m2 alloantigen has been shown to inhibit, in the presence of complement, in vitro formation by murine bone marrow cells of megakaryocyte colonies, but not granulocyte-macrophage, erythroid or eosinophil colonies. Inhibition of megakaryocyte colony formation was shown, by mixing and other experiments, to be due to C-mediated lysis of MEG-CFC rather than lysis of accessory cells. B-lymphocyte colony formation was reproducibly decreased by approximately 50%, demonstrating the presence of Qa-m2+ and Qa-m2- subsets of B-lymphocyte colony-forming cells (BL-CFC). MEG-CFC and granulocyte-macrophage colony-forming cells (GM-CFC) were also found to be Thy-1-, Ly-1-, Ly-6- and Ly-5-. Fractionation of Thy-1-, Ig- marrow by rosetting Qa-m2+ cells and centrifuging them through an Isopaque-Ficoll gradient yielded up to 8-fold enrichment for MEG-CFC and greater than 20-fold separation of MEG-CFC from GM-CFC. The anti-Qa-m2 antibody should be useful for further purification of MEG-CFC, and investigation of hemopoietic differentiation.